DANAHER CORP. 15/25DANAHER CORP. 15/25DANAHER CORP. 15/25

DANAHER CORP. 15/25

No trades
See on Supercharts

US235851AQ5 analysis



Key facts


Issue date
Sep 15, 2015
Maturity date
Sep 15, 2025
Outstanding amount
‪500.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
3.35% (Fixed)
Yield to maturity
4.68%
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.